Moleculin Biotech, Inc.
corporate_fare Company Profile
Moleculin Biotech, Inc. (NASDAQ:MBRX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 62 items for MBRX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Moleculin Biotech Regains Nasdaq Compliance, Averting Delisting
- Moleculin Biotech Seeks Shareholder Approval for Highly Dilutive Warrant Exercise to Raise $10.18M
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$33.56M
Op. Cash Flow
-$22.73M
Free Cash Flow
-$22.73M
Operating Income
-$25.1M
Cash & Equivalents
$8.88M
Debt / Equity
0.00×
Shares Outstanding
3.2M sh
Source: 10-K · filed 2026-04-14 · accession 0001437749-26-012273
show_chartPrice Chart
Loading chart...